SAFE CATTLE Act

HR3151 — SHIPS for America Act of 2025

Rebuild U.S. commercial shipbuilding and a U.S.-flag strategic fleet by pairing new tax credits, grants, and operating payments with stronger cargo-preference rules and workforce and innovation programs to restore domestic capacity and sealift readiness. It centralizes maritime strategy in a White House advisor and a Maritime Security Board and funds a broad set of industrial, port, and training programs to favor U.S.-built, U.S.-crewed vessels.

HR5401 — Pay Our Troops Act of 2026

Guarantees continued pay for military personnel during a federal funding gap. This bill would create a temporary appropriation to keep pay and allowances flowing for active-duty service members and the civilians and contractors who directly support them if FY2026 regular appropriations are not in effect.

HR4669 — FEMA Act of 2025

FEMA becomes an independent, cabinet-level agency with a clarified all-hazards mission and consolidated federal leadership for preparedness, response, recovery, mitigation, and interoperable communications. The bill also rewrites large parts of the Stafford Act to speed repairs, expand assistance, strengthen mitigation, and publish new public dashboards for disaster spending and individual aid metrics. - Families and disaster survivors: Expands housing help with a FEMA Emergency Home Repair program, authorizes direct repair assistance, and extends some temporary assistance periods from 18 to 24 months. Noncongregate sheltering can be provided without a fixed address and states cannot require a credit card for hoteling. - State, Tribal, and local governments and utilities: Creates expedited Section 409 grants for repairing public and qualifying nonprofit facilities with a Federal share floor of 75% and incentives up to 85% for resilience. Offers small-disaster block grants equal to 80% of the estimated Federal public assistance share and sets a Tribal hazard-mitigation minimum of $75.0 million per year. - Private nonprofits and houses of worship: Treats private nonprofits and houses of worship as eligible for assistance without regard to religious character and expands nonprofit closeout and eligibility parity with governments.

HR1262 — Mikaela Naylon Give Kids a Chance Act

Speeds and strengthens pediatric cancer drug development. It expands which cancer products companies must study in children, reshapes organ transplant network governance and fees, and adds new FDA international and transparency steps. - Children with cancer and researchers: Requires pediatric studies that produce clinically meaningful data on dosing, safety, and early effectiveness and widens the kinds of drug combinations studied. It also sets aside $25 million for pediatric drug studies in each of fiscal years 2026, 2027, and 2028. - Transplant patients and transplant network members: Changes Organ Procurement and Transplantation Network governance and financing by allowing quarterly registration fees, requiring those fees fund OPTN operations, improving electronic health record integration, and calling for a GAO review within two years. - FDA partners and drug makers: Creates an Abraham Accords Office to boost regulatory coordination and technical assistance abroad, and forces more transparency during generic (ANDA) reviews about whether generics are qualitatively and quantitatively the same as listed drugs. It also raises the Medicare Improvement Fund amount from $1.4 billion to $2.6 billion. Increases federal outlays by roughly $1.3 billion, driven by a $1.2 billion boost to the Medicare Improvement Fund and $75 million for pediatric studies, adding to federal spending.

HR1266 — Combating Illicit Xylazine Act

This bill would place xylazine on Schedule III of the Controlled Substances Act to curb illicit use and trafficking. It would also redefine who may possess xylazine legally, add the drug to federal tracking systems, and require sentencing guidance and periodic reports to Congress. - Veterinarians and animal owners: The bill limits who counts as an "ultimate user" to people who receive xylazine from a veterinarian or a registered pharmacy. Possession is restricted to animals they own or care for and to government or wildlife program uses. - Manufacturers and practitioners: Entities manufacturing xylazine at enactment would not have to install new capital security standards. Labeling rules are delayed for 1 year and practitioner registration, inventory, and recordkeeping requirements are delayed for 60 days to allow a transition. - Law enforcement and courts: Federal ARCOS tracking would be expanded to include xylazine. The U.S. Sentencing Commission must review penalties and the Attorney General, DEA, and FDA must report to Congress at 18 months and again at 4 years on prevalence, trafficking, and related risks.

HR842 — Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Would expand Medicare to cover multi-cancer early detection screening tests. It defines eligible tests as certain FDA-cleared or approved genomic blood tests or comparable biological-sample tests and directs the Secretary to use the national coverage determinations process to decide when they are covered.